-
1
-
-
0026648941
-
Genetic alterations in the adenomacarcinoma sequence
-
Cho KR, Vogelstein B. Genetic alterations in the adenomacarcinoma sequence. Cancer. 1992;70(Suppl):1727-1731.
-
(1992)
Cancer
, vol.70
, Issue.SUPPL.
, pp. 1727-1731
-
-
Cho, K.R.1
Vogelstein, B.2
-
2
-
-
0033135221
-
In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial
-
Herman JR, Adler HL, Aguilar-Cordova E, et al. In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. Hum Gene Ther. 1999;10:1239-1249.
-
(1999)
Hum Gene Ther
, vol.10
, pp. 1239-1249
-
-
Herman, J.R.1
Adler, H.L.2
Aguilar-Cordova, E.3
-
3
-
-
0036194178
-
Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer
-
Hasenburg A, Fischer DC, Tong XW, et al. Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer. Int J Gynecol Cancer. 2002;12:66-73.
-
(2002)
Int J Gynecol Cancer
, vol.12
, pp. 66-73
-
-
Hasenburg, A.1
Fischer, D.C.2
Tong, X.W.3
-
4
-
-
0029764224
-
IL-2 gene therapy of advanced lung cancer patients
-
Tan Y, Xu M, Wang W, et al. IL-2 gene therapy of advanced lung cancer patients. Anticancer Res. 1996;16:1993-1998.
-
(1996)
Anticancer Res
, vol.16
, pp. 1993-1998
-
-
Tan, Y.1
Xu, M.2
Wang, W.3
-
5
-
-
17344364798
-
Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancer
-
Heo DS, Yoon SJ, Kim WS, et al. Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2- microglobulin gene in patients with cancer. Hum Gene Ther. 1998;9:2031-2038.
-
(1998)
Hum Gene Ther
, vol.9
, pp. 2031-2038
-
-
Heo, D.S.1
Yoon, S.J.2
Kim, W.S.3
-
6
-
-
0029996360
-
Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins
-
Mesnil M, Piccoli, C, Tiraby G, Willecke K, Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA. 1996;93:1831-1835.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 1831-1835
-
-
Mesnil, M.1
Piccoli, C.2
Tiraby, G.3
Willecke, K.4
Yamasaki, H.5
-
7
-
-
85047698025
-
Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells
-
Burrows FJ, Gore M, Smiley WR, et al. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Cancer Gene Ther. 2002;9:87-95.
-
(2002)
Cancer Gene Ther
, vol.9
, pp. 87-95
-
-
Burrows, F.J.1
Gore, M.2
Smiley, W.R.3
-
8
-
-
0029609678
-
The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cells
-
Beck C, Cayeux S, Lupton SD, Dorken B, Blankenstein T. The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cells. Hum Gene Ther. 1995;6:1525-1530.
-
(1995)
Hum Gene Ther
, vol.6
, pp. 1525-1530
-
-
Beck, C.1
Cayeux, S.2
Lupton, S.D.3
Dorken, B.4
Blankenstein, T.5
-
9
-
-
0032505770
-
Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation
-
McMasters RA, Saylors RL, Jones KE, Hendrix ME, Moyer MP, Drake RR. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation. Hum Gene Ther. 1998;9:2253-2261.
-
(1998)
Hum Gene Ther
, vol.9
, pp. 2253-2261
-
-
McMasters, R.A.1
Saylors, R.L.2
Jones, K.E.3
Hendrix, M.E.4
Moyer, M.P.5
Drake, R.R.6
-
10
-
-
0034323468
-
Connexin-independent ganciclovir-mediated killing conferred on bystander effect-resistant cell lines by a herpes simplex virus-thymidine kinase-expressing colon cell line
-
Drake RR, Pitlyk K, McMasters RA, Mercer KE, Young H, Moyer MP. Connexin-independent ganciclovir-mediated killing conferred on bystander effect-resistant cell lines by a herpes simplex virus-thymidine kinase-expressing colon cell line. Mol Ther. 2000;2:515-523.
-
(2000)
Mol Ther
, vol.2
, pp. 515-523
-
-
Drake, R.R.1
Pitlyk, K.2
McMasters, R.A.3
Mercer, K.E.4
Young, H.5
Moyer, M.P.6
-
11
-
-
0030100158
-
Prodrug-activated gene therapy: Involvement of an immunological component in the "bystander effect"
-
Gagandeep S, Brew R, Green B, et al. Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect". Cancer Gene Ther. 1996;3:83-88.
-
(1996)
Cancer Gene Ther
, vol.3
, pp. 83-88
-
-
Gagandeep, S.1
Brew, R.2
Green, B.3
-
12
-
-
0031261851
-
Vaccination for experimental gliomas using GM-CSF-transduced glioma cells
-
Herrlinger U, Kramm CM, Johnston KM, et al. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. Cancer Gene Ther. 1997;4:345-352.
-
(1997)
Cancer Gene Ther
, vol.4
, pp. 345-352
-
-
Herrlinger, U.1
Kramm, C.M.2
Johnston, K.M.3
-
13
-
-
0030694629
-
Regression of established mouse leukemia by GM-CSF-transduced tumor vaccine: Implications for cytotoxic T lymphocyte responses and tumor burdens
-
Hsieh CL, Pang VF, Chen DS, Hwang LH. Regression of established mouse leukemia by GM-CSF-transduced tumor vaccine: implications for cytotoxic T lymphocyte responses and tumor burdens. Hum Gene Ther. 1997;8:1843-1854.
-
(1997)
Hum Gene Ther
, vol.8
, pp. 1843-1854
-
-
Hsieh, C.L.1
Pang, V.F.2
Chen, D.S.3
Hwang, L.H.4
-
14
-
-
0032822960
-
Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine
-
Kayaga J, Souberbielle BE, Sheikh N, et al. Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine. Gene Ther. 1999;6:1475-1481.
-
(1999)
Gene Ther
, vol.6
, pp. 1475-1481
-
-
Kayaga, J.1
Souberbielle, B.E.2
Sheikh, N.3
-
15
-
-
0031087213
-
Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors
-
Kruse CA, Roper MD, Kleinschmidt-DeMasters BK, et al. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors. Cancer Gene Ther. 1997;4:118-128.
-
(1997)
Cancer Gene Ther
, vol.4
, pp. 118-128
-
-
Kruse, C.A.1
Roper, M.D.2
Kleinschmidt-DeMasters, B.K.3
-
16
-
-
0027483695
-
The bystander effect: Tumor regression when a fraction of the tumor mass is genetically modified
-
Freeman SM, Abboud CN, Whartenby KA, et al. The bystander effect: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993;53:5274-5283.
-
(1993)
Cancer Res
, vol.53
, pp. 5274-5283
-
-
Freeman, S.M.1
Abboud, C.N.2
Whartenby, K.A.3
-
17
-
-
0015391488
-
Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adaptive derivative
-
Rockwell SC, Kallmann RF, Fajardo LF. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adaptive derivative. J Natl Cancer Inst. 1972;49:735-747.
-
(1972)
J Natl Cancer Inst
, vol.49
, pp. 735-747
-
-
Rockwell, S.C.1
Kallmann, R.F.2
Fajardo, L.F.3
-
18
-
-
0031836745
-
Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model
-
Bonnekoh B, Greenhalgh DA, Chen SH, et al. Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model. J Invest Dermatol. 1998;110:867-871.
-
(1998)
J Invest Dermatol
, vol.110
, pp. 867-871
-
-
Bonnekoh, B.1
Greenhalgh, D.A.2
Chen, S.H.3
-
19
-
-
0036244445
-
Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice
-
Warren P, Song W, Holle E, et al. Combined HSV-TK/ GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice. Anticancer Res. 2002;22:599-604.
-
(2002)
Anticancer Res
, vol.22
, pp. 599-604
-
-
Warren, P.1
Song, W.2
Holle, E.3
-
20
-
-
0141748260
-
Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: Decrease of oncogenicity and induction of protection
-
Janouskova O, Sima P, Kunke D. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection. Int J Oncol. 2003;22:569-577.
-
(2003)
Int J Oncol
, vol.22
, pp. 569-577
-
-
Janouskova, O.1
Sima, P.2
Kunke, D.3
-
21
-
-
0032502845
-
Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase
-
Boucher PD, Ruch RJ, Shewach DS. Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase. Human Gene Ther. 1998;9:801-814.
-
(1998)
Human Gene Ther
, vol.9
, pp. 801-814
-
-
Boucher, P.D.1
Ruch, R.J.2
Shewach, D.S.3
-
22
-
-
0027291236
-
Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
-
Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA. 1993;90:7024-7028.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 7024-7028
-
-
Caruso, M.1
Panis, Y.2
Gagandeep, S.3
Houssin, D.4
Salzmann, J.L.5
Klatzmann, D.6
-
23
-
-
0029737399
-
Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Ki-ras(G12V)
-
Pavlovic J, Nawrath M, Tu R, Heinicke T, Moelling K. Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Ki-ras(G12V). Gene Therapy. 1996;3:635-643.
-
(1996)
Gene Therapy
, vol.3
, pp. 635-643
-
-
Pavlovic, J.1
Nawrath, M.2
Tu, R.3
Heinicke, T.4
Moelling, K.5
-
24
-
-
0029877716
-
Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells
-
Armstrong CA, Botella R, Galloway TH, et al. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res. 1996;56:2191-2198.
-
(1996)
Cancer Res
, vol.56
, pp. 2191-2198
-
-
Armstrong, C.A.1
Botella, R.2
Galloway, T.H.3
-
25
-
-
0029740524
-
Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: Sustained antitumor immunity prolongs animal survival
-
Chen SH, Kosai K, Xu B, et al. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res. 1996;56:3758-3762.
-
(1996)
Cancer Res
, vol.56
, pp. 3758-3762
-
-
Chen, S.H.1
Kosai, K.2
Xu, B.3
-
26
-
-
0030854533
-
Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells
-
Yu JS, Burwick JA, Dranoff G, Breakefield XO. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells. Hum Gene Ther. 1997;8: 1065-1072.
-
(1997)
Hum Gene Ther
, vol.8
, pp. 1065-1072
-
-
Yu, J.S.1
Burwick, J.A.2
Dranoff, G.3
Breakefield, X.O.4
-
27
-
-
0033191074
-
Recombinant interferon alpha2a synergistically enhances ganciclovir-mediated tumor cell killing in the herpes simplex virus thymidine kinase system
-
Whartenby KA, Darnowski JW, Freeman SM, Yurasha K, Calabresi P. Recombinant interferon alpha2a synergistically enhances ganciclovir-mediated tumor cell killing in the herpes simplex virus thymidine kinase system. Cancer Gene Ther. 1999;6:402-408.
-
(1999)
Cancer Gene Ther
, vol.6
, pp. 402-408
-
-
Whartenby, K.A.1
Darnowski, J.W.2
Freeman, S.M.3
Yurasha, K.4
Calabresi, P.5
-
28
-
-
0028224859
-
Regulation of recombinant human granulocyte colony-stimulating factor production using herpes simplex virus 1 thymidine kinase gene
-
Aoki Y, Tani K, Takahashi K, Fukushima M, Ozawa K, Asano S. Regulation of recombinant human granulocyte colony-stimulating factor production using herpes simplex virus 1 thymidine kinase gene. Biochem Biophys Res Commun. 1994;200:1245-1251.
-
(1994)
Biochem Biophys Res Commun
, vol.200
, pp. 1245-1251
-
-
Aoki, Y.1
Tani, K.2
Takahashi, K.3
Fukushima, M.4
Ozawa, K.5
Asano, S.6
-
29
-
-
0029033192
-
Targeted ablation of pituitary pre-proopiomelanocortin cells by herpes simplex virus-1 thymidine kinase differentially regulates mRNAs encoding the adrenocorticotropin receptor and aldosterone synthase in the mouse adrenal gland
-
Allen RG, Carey C, Parker JD, Mortrud MT, Mellon SH, Low MJ. Targeted ablation of pituitary pre-proopiomelanocortin cells by herpes simplex virus-1 thymidine kinase differentially regulates mRNAs encoding the adrenocorticotropin receptor and aldosterone synthase in the mouse adrenal gland. Mol Endocrinol. 1995;9:1005-1016.
-
(1995)
Mol Endocrinol
, vol.9
, pp. 1005-1016
-
-
Allen, R.G.1
Carey, C.2
Parker, J.D.3
Mortrud, M.T.4
Mellon, S.H.5
Low, M.J.6
|